Gay men taking daily anti-HIV pills are sexually non-infectious, says major study

Men who take the pills daily are sexually non-infectious, a new study has revealed
Justin Sullivan/Getty Images

Gay men who take daily anti-HIV pills can have unprotected sex without transmitting the Aids virus to their partner, major research confirmed today.

The eight-year study, led by University College London , found the men whose “viral load” was reduced to undetectable levels by antiretroviral therapy (ART) were “sexually non-infectious”.

The results backed up an earlier study, which found HIV transmission risk for heterosexual couples was zero.

Experts said the preliminary findings — being presented at Aids 2018, a public health conference being held this week in Amsterdam — highlighted the importance of early detection of HIV in preventing the spread of the disease.

ART involves taking pills daily to stop the HIV virus replicating. The Partner2 study followed almost 1,000 gay couples from 14 countries where one partner was HIV positive and on ART and the other was HIV negative. There were almost 77,000 episodes of condomless sex between 2010 and 2018, with no linked HIV infections.

Dr Alison Rodger, of UCL Institute for Global Health, said: “The study was designed to find whether HIV transmission occurs in gay men when viral load was suppressed. Despite these couples having sex without condoms, 75,000 times we did not find a single case.

“Partner2 data provides robust evidence that the risk of HIV transmission with suppressive ART is effectively zero. These results underline the importance of earlier diagnosis and treatment and will improve the quality of life for HIV positive people and their partners.” Deborah Gold, chief executive of the National Aids Trust, said: “This is all the more reason to ramp up efforts on testing for HIV.”

A bid to cure HIV by “waking” then eradicating HIV in ART patients has failed. Researchers hoped forcing HIV out of “hiding” to destroy it could have enabled patients to stop taking daily medication. But a three-year trial found no difference in patients’ HIV levels.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in

MORE ABOUT